Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5277_Библиотеки_им_академика_М_И_Перельмана.pdf
78 Bioactive Glass Materials for Biological Applications
performance in vivo. Modifying the ratios of silicon, calcium, and other constitu-
ents in the bioactive glass can improve its biological interactions and degradation
behaviour. Techniques such as surface roughening, coating with bioactive mol-
ecules, or creating specic topographies can enhance cell adhesion, proliferation,
and integration in vivo.
5.4.2 hydroxyapatite layer formation
5.4.2.1 In Vitro Hydroxyapatite Formation
In vitro studies using SBF immersion tests provide insights into the bioactivity
of bioactive glasses by examining the formation of a HA layer on their surfaces.
Techniques such as XRD, FTIR, and SEM are used to detect and characterize the
HA. The rate of formation, as well as the quality and thickness of the HA layer, are
key indicators of the material’s osteoconductivity.
5.4.2.1.1 Simulated Body Fluid Immersion Tests
Preparation and Procedure
• Simulated Body Fluid: SBF is an aqueous solution with ion concentrations
similar to those of human blood plasma. It is prepared following established
protocols to ensure consistency and reproducibility in testing.
• Immersion Process: Bioactive glass samples are immersed in SBF at 37°C,
typically for varying periods ranging from a few hours to several weeks. The
solution is periodically refreshed to maintain constant ion concentrations.
• Monitoring: The immersion process is monitored to observe the formation
and growth of the HA layer on the bioactive glass surface.
Characterization Techniques
1. X‑ray Diffraction
• Phase Identication: XRD is used to identify crystalline phases present
on the surface of bioactive glass after immersion in SBF. The appearance
of characteristic peaks corresponding to HA conrms its formation.
• Crystallinity: The degree of crystallinity of the HA layer is assessed, as
higher crystallinity often correlates with better biological performance
and mechanical properties.
2. Fourier‑Transform Infrared Spectroscopy
• Chemical Composition: FTIR provides information on the chemi-
cal bonds and functional groups present in the HA layer. The presence
of phosphate (PO
4
3−
) and hydroxyl (OH
−
) groups is indicative of HA
formation.
• Structural Analysis: FTIR spectra can reveal the structural similari-
ties between the formed HA layer and natural bone mineral, providing
insights into the quality of the HA.
3. Scanning Electron Microscopy
• Morphological Analysis: SEM is employed to visualize the surface
morphology of the bioactive glass after SBF immersion. High-resolution
images reveal the topographical features and uniformity of the HA layer.
79In Vivo and In Vitro Behaviours of Bioactive Glass Materials
• Thickness Measurement: Cross‑sectional SEM analysis can be used to
measure the thickness of the HA layer, which is critical for evaluating
the extent of bioactivity.
• Elemental Analysis: EDS, often coupled with SEM, provides elemental
composition data, conrming the presence of calcium (Ca) and phospho‑
rus (P) in the correct ratios for HA.
5.4.2.1.2 Key Indicators of Osteoconductivity
1. Rate of Formation
• Kinetics: The rate at which the HA layer forms on the bioactive glass
surface is a crucial indicator of bioactivity. Faster formation rates suggest
higher bioactivity and better potential for promoting bone regeneration.
2. Quality of the Hydroxyapatite Layer
• Crystallinity and Purity: High‑quality HA layers are characterized by
high crystallinity and purity, which are essential for optimal biological
per formance.
• Structural Integrity: The structural integrity of the HA layer, includ‑
ing its ability to withstand mechanical stresses without degradation, is
important for its functionality in vivo.
3. Thickness of the Hydroxyapatite Layer
• Uniformity and Coverage: A uniform and adequately thick HA layer
covering the entire bioactive glass surface ensures consistent bioactivity
and effective bonding with bone tissue.
• Functional Thickness: The thickness of the HA layer should be sufcient
to provide a conducive environment for cell attachment and proliferation,
but not so thick as to impede the material’s mechanical properties.
In vitro HA formation studies using SBF immersion tests are fundamental for evalu‑
ating the bioactivity of bioactive glasses. Techniques such as XRD, FTIR, and SEM
are employed to detect and characterize the HA layer formed on the material’s sur‑
face. Key indicators of osteoconductivity include the rate of HA formation, and the
quality and thickness of the HA layer. These studies provide essential data that help
optimize the composition and design of bioactive glasses for effective bone regenera‑
tion and other medical applications.
5.4.2.2 In Vivo Hydroxyapatite Formation
In vivo, the formation of a HA layer on bioactive glass implants is assessed through
histological and imaging techniques. The presence of HA on the material surface,
along with new bone growth around the implant, signies successful integration and
osteoconductivity. The quality and uniformity of the HA layer are critical for ensur‑
ing strong bonding between the implant and bone tissue.
5.4.2.2.1 Assessment Techniques
1. Histological Analysis
• Tissue Sampling: Tissue samples from around the implant site are col‑
lected at various time points post‑implantation. These samples are pro‑
cessed and stained to visualize the bone‑implant interface.
80 Bioactive Glass Materials for Biological Applications
• Staining Methods: Common staining methods include H&E for general
tissue structure, Masson’s Trichrome for collagen and bone matrix, and
Von Kossa or Alizarin Red for mineralized tissue.
• Histomorphometry: Quantitative histological techniques measure
parameters such as new bone area, BIC, and HA layer thickness. These
metrics are critical for assessing the extent and quality of HA formation
and bone integration.
2. Imaging Techniques
• X‑ray Microtomography (Micro‑CT)
– 3D Visualization: Micro‑CT provides high‑resolution, three‑
dimensional images of the implant and surrounding bone, allowing
for detailed analysis of bone architecture and density.
– Quantitative Analysis: Micro‑CT scan quantify bone volume, tra‑
becular thickness, and other parameters that indicate the degree of
bone regeneration and integration with the bioactive glass.
• Scanning Electron Microscopy
– Surface Morphology: SEM is used to examine the surface morphol‑
ogy of explanted bioactive glass. It reveals the presence and unifor‑
mity of the HA layer, as well as the microstructural details of the
bone‑implant interface.
– Elemental Composition: EDS coupled with SEM provides elemen‑
tal analysis, conrming the presence of calcium and phosphorus
indicative of HA.
• Transmission Electron Microscopy
– Nanoscale Analysis: TEM offers insights into the ultrastructural
organization of the HA layer and the bone‑implant interface at the
nanoscale level, providing detailed information on crystallinity and
bonding characteristics.
5.4.2.2.2 Indicators of Successful HA Formation
1. Presence of Hydroxyapatite
• Detection: The formation of HA on the surface of the bioactive glass
implant is conrmed through imaging and histological staining. The
presence of characteristic mineral deposits around the implant site indi‑
cates bioactivity.
• Integration: Successful integration is marked by the seamless transition
between the HA layer and newly formed bone, with no signicant gaps
or brotic tissue intervening.
2. New Bone Growth
• Osteoconductivity: The ability of the bioactive glass to support new
bone growth is a direct measure of its osteoconductivity. Histological
and imaging studies assess the extent and quality of new bone formation
around the implant.
• Bone‑Implant Contact: High levels of direct BIC are indicative of
strong bonding and effective integration. This contact is essential for the
mechanical stability of the implant.
81In Vivo and In Vitro Behaviours of Bioactive Glass Materials
3. Quality and Uniformity of Hydroxyapatite Layer
• Crystallinity: High crystallinity of the HA layer is crucial for mimick‑
ing the mineral phase of natural bone and ensuring optimal mechanical
properties.
• Uniformity and Coverage: A uniform HA layer with consistent thick‑
ness across the implant surface ensures comprehensive bioactivity and
effective bonding with the host bone tissue.
In vivo assessment of HA formation on bioactive glass implants is a critical step in
validating their efcacy and biocompatibility. Advanced histological and imaging
techniques, such as histomorphometry, micro‑CT, SEM, and TEM, provide compre‑
hensive insights into the presence, quality, and uniformity of the HA layer. The suc‑
cessful formation of HA and new bone growth around the implant signify effective
osteoconductivity and integration, ensuring strong bonding between the bioactive
glass and bone tissue. These in vivo evaluations are essential for optimizing bioactive
glass materials for clinical applications in bone regeneration and other medical elds.
5.4.3 Ion Release KInetIcs
5.4.3.1 In Vitro Ion Release
In vitro ion release studies involve immersing bioactive glasses in SBF or other
relevant solutions and measuring the concentrations of released ions over time.
Techniques like ICP‑OES are used to quantify the release of key ions such as cal‑
cium, phosphate, and silicon. The kinetics of ion release are important for under‑
standing the material’s dissolution behaviour and subsequent bioactivity.
5.4.3.1.1 Experimental Procedure
1. Preparation of Bioactive Glass Samples
• Sample Selection: Bioactive glass samples are prepared in various
forms, such as powders, pellets, or thin lms, depending on the specic
study requirements.
• Surface Area Considerations: The surface area of the samples is care‑
fully measured as it inuences the rate of ion release.
2. Immersion in Simulated Body Fluid
• Solution Composition: SBF is prepared to mimic the ionic composi‑
tion of human blood plasma, ensuring that the experimental conditions
closely replicate physiological environments.
• Immersion Conditions: Bioactive glass samples are immersed in SBF
at 37°C, with the solution typically refreshed periodically to maintain
constant ionic concentrations.
3. Measurement of Ion Release
• Time Points: Samples of the immersion solution are collected at various
time points, ranging from a few hours to several days or weeks, to moni‑
tor the kinetics of ion release.
• Quantication Techniques: Inductively ICP‑OES is commonly used
to quantify the concentrations of released ions such as calcium (Ca
2+
),
phosphate (PO
4
3−
), and silicon (Si
4+
).
82 Bioactive Glass Materials for Biological Applications
5.4.3.1.2 Analytical Techniques
1. Inductively Coupled Plasma Optical Emission Spectrometry
• Principle: ICP‑OES involves ionizing the sample solution with an
inductively coupled plasma and measuring the emitted light at specic
wavelengths corresponding to the ions of interest.
• Quantication: This technique provides precise and accurate measure‑
ments of ion concentrations, allowing for detailed analysis of the disso‑
lution behaviour of bioactive glasses.
2. Complementary Techniques
• Atomic Absorption Spectroscopy: Sometimes used alongside ICP‑OES
for cross‑validation of ion concentration data.
• Ion Chromatography (IC): Can be employed for the separation and
quantication of specic ions in the solution.
5.4.3.1.3 Kinetics of Ion Release
1. Initial Burst Release
• Surface Dissolution: The initial stage of ion release often involves a
burst release of ions from the bioactive glass surface. This is attributed
to the rapid dissolution of the surface layer when rst exposed to SBF.
• Bioactivity Indication: A signicant initial release of calcium and phos‑
phate ions is indicative of the glass’s bioactivity, as these ions play a criti‑
cal role in the formation of HA.
2. Sustained Release
• Controlled Dissolution: Following the initial burst, the ion release
typically transitions to a more controlled, sustained release phase. This
phase is inuenced by the glass composition and the network connectiv‑
ity of the material.
• Long‑term Behaviour: The sustained release of silicon and other ions
supports ongoing biological processes such as angiogenesis and osteo‑
genesis over extended periods.
3. Factors Inuencing Ion Release
• Glass Composition: The specic composition of the bioactive glass,
including the types and proportions of constituent oxides, signicantly
affects the rate and pattern of ion release.
• pH and Ionic Strength of Solution: The pH and ionic strength of the
SBF or other immersion solutions can alter the dissolution kinetics,
impacting the overall bioactivity of the material.
• Surface Area and Porosity: The physical characteristics of the bioac‑
tive glass, including surface area and porosity, inuence the rate at which
ions are released into the solution.
In vitro ion release studies provide critical data on the dissolution behaviour and
bioactivity of bioactive glasses. By immersing bioactive glass samples in SBF and
measuring the concentrations of released ions over time using techniques such as
ICP‑OES, researchers can gain valuable insights into the kinetics of ion release.
This information is essential for understanding how bioactive glasses interact with
83In Vivo and In Vitro Behaviours of Bioactive Glass Materials
biological environments, predicting their performance in vivo, and optimizing their
compositions for various medical applications.
5.4.3.2 In Vivo Ion Release
In vivo, the release of ions from bioactive glass implants into the surrounding tissues
and uids is monitored to understand their role in promoting tissue regeneration and
healing. The ionic composition of local biological uids and tissues is analysed to
detect any changes induced by the bioactive glass. These studies help in assessing
the biological impact of ion release and its contribution to the overall performance
of the implant.
5.4.3.2.1 Monitoring Ion Release In Vivo
1. Implantation and Sample Collection
• Animal Models: Bioactive glass implants are typically evaluated in
appropriate animal models, such as rodents, rabbits, or larger mammals,
depending on the study’s objectives and relevance to human physiology.
• Implantation Sites: The bioactive glass can be implanted in various
anatomical locations, such as bone defects, dental sites, or soft tissue, to
study its specic application.
• Sampling Intervals: Biological uids (e.g., blood, serum, intersti‑
tial uid) and tissue samples are collected at predened time points
post‑implantation to monitor ion release over time.
2. Quantication of Released Ions
• Analytical Techniques: Techniques such as inductively ICP‑OES,
ICP‑MS, and AAS are used to measure the concentrations of key ions,
including calcium (Ca
2+
), phosphate (PO
4
3−
), and silicon (Si
4+
).
• Localization: Spatial analysis of ion concentrations within different tis‑
sue compartments helps in understanding the diffusion and distribution
of released ions.
5.4.3.2.2 Biological Impact of Ion Release
1. Tissue Regeneration and Healing
• Osteogenesis: The release of calcium and phosphate ions from bioactive
glass implants supports the formation of new bone by providing essential
building blocks for HA formation and stimulating osteoblast activity.
• Angiogenesis: Silicon ions have been shown to promote angiogenesis,
the formation of new blood vessels, which is critical for supplying nutri‑
ents and oxygen to regenerating tissues.
2. Modulation of Cellular Activity
• Cell Proliferation and Differentiation: Released ions can inuence the
behaviour of various cell types, including osteoblasts, broblasts, and
endothelial cells, enhancing their proliferation and differentiation.
• Inammatory Response: The ionic environment created by the dis‑
solution of bioactive glass can modulate the inammatory response,
potentially reducing chronic inammation and promoting a conducive
environment for healing.
84 Bioactive Glass Materials for Biological Applications
5.4.3.2.3 Analysis of Biological Fluids and Tissues
1. Ionic Composition Analysis
• Fluid Analysis: The ionic composition of local biological uids, such as
blood plasma or interstitial uid, is analysed to detect changes induced
by the bioactive glass implant. This includes measuring the concentra‑
tions of calcium, phosphate, silicon, and other relevant ions.
• Tissue Analysis: Tissue samples from the implant site are analysed for
ion content and distribution. Techniques such as EDS coupled with SEM
provide detailed elemental analysis.
2. Histological and Histochemical Studies
• Histological Staining: Techniques such as H&E staining, Masson’s
Trichrome, and Von Kossa staining are used to visualize tissue structure,
collagen deposition, and mineralization, respectively.
• Histochemical Analysis: Immunohistochemical staining for markers of
osteogenesis (e.g., osteocalcin, osteopenia) and angiogenesis (e.g., CD31,
VEGF) provides insights into the biological processes inuenced by ion
release.
5.4.3.2.4 Assessing Implant Performance
1. Integration and Bonding
• Bone‑Implant Interface: The quality of the bond between the bioactive
glass implant and the surrounding bone is assessed through histomor‑
phometric analysis and imaging techniques. A strong, continuous bond
is indicative of successful integration.
• Mechanical Stability: The mechanical properties of the regenerated tis‑
sue and the implant’s ability to withstand physiological loads are evalu‑
ated through mechanical testing and nite element analysis.
2. Long‑Term Effects
• Sustained Ion Release: Long‑term studies monitor the sustained release
of ions and their effects on tissue health and regeneration over extended
periods. This is crucial for understanding the durability and effective‑
ness of the implant.
• Biocompatibility and Safety: The systemic effects of ion release, includ‑
ing potential toxicity and overall biocompatibility, are assessed through
blood tests, organ function analysis, and histopathological examination.
5.4.3.3 Correlating In Vitro and In Vivo Ion Release Data
Correlating ion release data from in vitro and in vivo studies involves comparing the
kinetics and concentrations of released ions in both environments. Consistent ion release
proles across both settings indicate a predictable dissolution behaviour and bioactiv‑
ity of the material. Variations in ion release can highlight differences in the biological
environment and help in adjusting the glass composition for optimal performance.
5.4.3.3.1 Comparative Analysis of Ion Release Data
1. Kinetics of Ion Release
• Initial Burst Release: Both in vitro and in vivo studies often show
an initial rapid release of ions, particularly calcium (Ca
2+
), phosphate
85In Vivo and In Vitro Behaviours of Bioactive Glass Materials
(PO
4
3−
), and silicon (Si
4+
), due to the dissolution of the bioactive glass
surface. Comparing the rate and extent of this initial release helps to
validate the material’s bioactivity.
• Sustained Release Phase: After the initial burst, a more controlled, sus‑
tained release phase follows. Correlating the duration and rate of this
phase in vitro and in vivo is crucial for predicting the long‑term perfor‑
mance and bioactivity of the implant.
2. Concentrations of Released Ions
• Quantitative Measurement: Techniques such as ICP‑OES and ICP‑MS
are used to measure the concentrations of released ions in both in vitro
and in vivo samples. Consistent concentration proles suggest that the in
vitro environment successfully mimics the in vivo conditions.
• Threshold Levels: Ensuring that the ion concentrations reach therapeu‑
tic levels necessary for promoting osteogenesis, angiogenesis, and other
regenerative processes without causing toxicity or adverse reactions.
5.4.3.3.2 Interpretation of Correlation Data
1. Predictable Dissolution Behaviour
• Consistency in Data: Consistent ion release proles in vitro and
in vivo indicate that the bioactive glass has a predictable dissolu‑
tion behaviour, enhancing condence in its performance for clinical
applications.
• Validation of In Vitro Models: When in vitro ion release data accu‑
rately predict in vivo behaviour, it validates the use of in vitro models
for initial screening and optimization of bioactive glass compositions.
2. Variations and Their Implications
• Biological Environment Differences: Variations in ion release proles
between in vitro and in vivo studies can highlight differences in the bio‑
logical environment, such as pH variations, presence of enzymes, and
dynamic uid ow in vivo.
• Adjustment of Composition: Identifying these differences allows
researchers to adjust the composition of the bioactive glass to bet‑
ter suit the in vivo conditions, enhancing its bioactivity and overall
per formance.
5.4.3.3.3 Applications of Correlated Data
1. Optimization of Bioactive Glass Compositions
• Tailoring Ion Release: By understanding the specic ion release kinet‑
ics required for different medical applications, bioactive glass composi‑
tions can be tailored to optimize their therapeutic effects.
• Enhanced Bioactivity: Adjustments based on correlated data can
enhance the material’s ability to support bone regeneration, wound heal‑
ing, and other regenerative processes.
2. Clinical Translation
• Predictive Modelling: Reliable in vitro to in vivo correlation allows for
the development of predictive models that can expedite the translation of
bioactive glass materials from the laboratory to clinical settings.
86 Bioactive Glass Materials for Biological Applications
• Regulatory Approval: Consistent and predictable ion release proles
support the case for regulatory approval by demonstrating the material’s
safety, efcacy, and reliability.
5.4.3.3.4 Methodological Considerations
1. Standardized Protocols
• Reproducibility: Using standardized protocols for both in vitro and in
vivo studies ensure reproducibility and comparability of ion release data.
• Controlled Variables: Carefully controlling variables such as temper‑
ature, pH, and immersion uid composition in vitro can help achieve
more accurate correlations with in vivo data.
2. Advanced Analytical Techniques
• High‑Resolution Imaging: Techniques such as SEM, TEM, and XRD
provide detailed information on the microstructural changes in bioactive
glass during dissolution, complementing ion release data.
• Elemental Analysis: Combining ion concentration measurements with
elemental analysis of tissues and uids provides a comprehensive under‑
standing of the material’s behaviour in vivo.
5.5 APPLICATIONS OF BIOACTIVE GLASS
MATERIALS IN BIOMEDICAL FIELDS
In vitro tests, although simplied, offer valuable predictive data regarding the poten‑
tial performance of bioactive glasses in vivo. Consistent ndings between in vitro
and in vivo studies enhance the reliability of preliminary laboratory tests as predic‑
tors of clinical outcomes. The unique properties of bioactive glass materials make
them highly versatile for a range of biomedical applications. This section explores
the specic uses of bioactive glasses in bone regeneration, dental restoration, and
drug delivery systems, highlighting their advantages and contributions to advancing
medical treatments (Figure5.4).
5.5.1 Bone RegeneRatIon
Bone regeneration is a complex process that aims to repair or replace damaged or
lost bone tissue. Bioactive glasses have emerged as a promising class of biomateri‑
als for this purpose due to their unique ability to, unlike traditional biomaterials,
bioactive glasses don’t simply sit inertly within the body. They actively partici‑
pate in the healing process by forming a hydroxyapatite (HA) layer on their sur‑
face. HAp is the primary mineral component of bone, and its presence facilitates
a strong bond between the implant and surrounding bone tissue, known as osseo‑
integration. This strong bond is crucial for long‑term implant stability and func‑
tionality. Beyond osseointegration, bioactive glasses actively stimulate new bone
formation. As the HAp layer forms, it serves as a scaffold, attracting and guiding
bone‑forming cells (osteoblasts) to migrate towards the implant. These osteoblasts
then deposit new bone matrix on the HAp surface, promoting bone regeneration at
the defect site [13].
87In Vivo and In Vitro Behaviours of Bioactive Glass Materials
5.5.2 applications in orthopaedics and dentistry
Bioactive glasses nd numerous applications in orthopaedics and dentistry for bone
regeneration, including:
• Bone Defect Repair: Filling gaps or voids in bone caused by trauma, dis-
ease, or surgery.
• Spinal Fusion: Promoting bone growth between vertebrae for spinal
stabilization.
• Treatment of Bone Fractures: Assisting the healing process in complex
fractures.
• Dental Implants: Providing a strong and biocompatible foundation for den-
tal restorations.
• Periodontal Regeneration: Encouraging bone regrowth around teeth with
bone loss.
Bioactive glasses represent a signicant advancement in bone regeneration strategies.
Their ability to mimic the natural bone environment and actively participate in the
healing process makes them valuable tools for orthopaedic surgeons and dentists.
As research continues to explore their full potential, bioactive glasses hold promise
for revolutionizing the treatment of bone-related conditions and improving patient
outcomes.
5.5.2.1 Orthopaedic Implants
Bioactive glasses are used in various orthopaedic implants to repair and regener-
ate bone tissue. Their bioactivity promotes the formation of a HA layer, which
facilitates the bonding of the implant to the bone. This property is particularly
benecial in treating bone defects and fractures, enhancing the stability and
integration of implants [14, 15]. Unlike traditional implant materials, bioactive
FIGURE5.4 Application of bioactive glass in dentistry [12]